APO Research
Talk to an analyst

APO RESEARCH · REPORT

Swine Epidemic Diarrhea Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Swine Epidemic Diarrhea Vaccines Market Outlook and Growth Opportunities 2026

2 January 2026199 pages

Choose your research edition.

Industry ResearchSwine Epidemic Diarrhea Vaccines Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Swine Epidemic Diarrhea Vaccines Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal Swine Epidemic Diarrhea Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Swine Epidemic Diarrhea Vaccines Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Swine Epidemic Diarrhea Vaccines Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Swine Epidemic Diarrhea Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Swine Epidemic Diarrhea Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Swine Epidemic Diarrhea Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Swine Epidemic Diarrhea Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Swine Epidemic Diarrhea Vaccines market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Swine Epidemic Diarrhea Vaccines market include CAVAC, Qilu Animal Health, Zoetis, Nisseiken, Komipharm, Harrisvaccines, Inc. and Green Cross Veterinary Products, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Swine Epidemic Diarrhea Vaccines market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Swine Epidemic Diarrhea Vaccines and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Swine Epidemic Diarrhea Vaccines revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Swine Epidemic Diarrhea Vaccines market.

Swine Epidemic Diarrhea Vaccines Segment by Company

CAVAC

Qilu Animal Health

Zoetis

Nisseiken

Komipharm

Harrisvaccines, Inc.

Green Cross Veterinary Products

Swine Epidemic Diarrhea Vaccines Segment by Type

Live Vaccines

Killed Vaccines

Swine Epidemic Diarrhea Vaccines Segment by Application

Piglets

Adults Pigs

Swine Epidemic Diarrhea Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Swine Epidemic Diarrhea Vaccines status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Swine Epidemic Diarrhea Vaccines key companies, revenue, market share, and recent developments.

3. To split the Swine Epidemic Diarrhea Vaccines breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Swine Epidemic Diarrhea Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Swine Epidemic Diarrhea Vaccines significant trends, drivers, influence factors in global and regions.

6. To analyze Swine Epidemic Diarrhea Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Swine Epidemic Diarrhea Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Swine Epidemic Diarrhea Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Swine Epidemic Diarrhea Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Swine Epidemic Diarrhea Vaccines industry.

Chapter 3: Detailed analysis of Swine Epidemic Diarrhea Vaccines company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Swine Epidemic Diarrhea Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Swine Epidemic Diarrhea Vaccines in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Swine Epidemic Diarrhea Vaccines Industry Trends Table 2. Swine Epidemic Diarrhea Vaccines Industry Drivers Table 3. Swine Epidemic Diarrhea Vaccines Industry Opportunities and Challenges Table 4. Swine Epidemic Diarrhea Vaccines Industry Restraints Table 5. Global Swine Epidemic Diarrhea Vaccines Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Swine Epidemic Diarrhea Vaccines Revenue Share by Company (2021-2026) Table 7. Global Swine Epidemic Diarrhea Vaccines Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Swine Epidemic Diarrhea Vaccines Key Company Manufacturing Base & Headquarters Table 9. Global Swine Epidemic Diarrhea Vaccines Company, Product Type & Application Table 10. Global Swine Epidemic Diarrhea Vaccines Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Swine Epidemic Diarrhea Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Live Vaccines Table 15. Significant Companies of Killed Vaccines Table 16. Global Swine Epidemic Diarrhea Vaccines Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Swine Epidemic Diarrhea Vaccines Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Swine Epidemic Diarrhea Vaccines Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Swine Epidemic Diarrhea Vaccines Sales Value Share by Type (2021-2026) Table 20. Global Swine Epidemic Diarrhea Vaccines Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Piglets Table 22. Significant Companies of Adults Pigs Table 23. Global Swine Epidemic Diarrhea Vaccines Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Swine Epidemic Diarrhea Vaccines Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Swine Epidemic Diarrhea Vaccines Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Swine Epidemic Diarrhea Vaccines Sales Value Share by Application (2021-2026) Table 27. Global Swine Epidemic Diarrhea Vaccines Sales Value Share by Application (2027-2032) Table 28. Global Swine Epidemic Diarrhea Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Swine Epidemic Diarrhea Vaccines Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Swine Epidemic Diarrhea Vaccines Sales Value Share by Region (2021-2026) Table 31. Global Swine Epidemic Diarrhea Vaccines Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Swine Epidemic Diarrhea Vaccines Sales Value Share by Region (2027-2032) Table 33. Global Swine Epidemic Diarrhea Vaccines Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Swine Epidemic Diarrhea Vaccines Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Swine Epidemic Diarrhea Vaccines Sales Value Market Share by Country (2021-2026) Table 36. Global Swine Epidemic Diarrhea Vaccines Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Swine Epidemic Diarrhea Vaccines Sales Value Market Share by Country (2027-2032) Table 38. CAVAC Company Information Table 39. CAVAC Business Overview Table 40. CAVAC Swine Epidemic Diarrhea Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. CAVAC Swine Epidemic Diarrhea Vaccines Product Portfolio Table 42. CAVAC Recent Development Table 43. Qilu Animal Health Company Information Table 44. Qilu Animal Health Business Overview Table 45. Qilu Animal Health Swine Epidemic Diarrhea Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Qilu Animal Health Swine Epidemic Diarrhea Vaccines Product Portfolio Table 47. Qilu Animal Health Recent Development Table 48. Zoetis Company Information Table 49. Zoetis Business Overview Table 50. Zoetis Swine Epidemic Diarrhea Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Zoetis Swine Epidemic Diarrhea Vaccines Product Portfolio Table 52. Zoetis Recent Development Table 53. Nisseiken Company Information Table 54. Nisseiken Business Overview Table 55. Nisseiken Swine Epidemic Diarrhea Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Nisseiken Swine Epidemic Diarrhea Vaccines Product Portfolio Table 57. Nisseiken Recent Development Table 58. Komipharm Company Information Table 59. Komipharm Business Overview Table 60. Komipharm Swine Epidemic Diarrhea Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Komipharm Swine Epidemic Diarrhea Vaccines Product Portfolio Table 62. Komipharm Recent Development Table 63. Harrisvaccines, Inc. Company Information Table 64. Harrisvaccines, Inc. Business Overview Table 65. Harrisvaccines, Inc. Swine Epidemic Diarrhea Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Harrisvaccines, Inc. Swine Epidemic Diarrhea Vaccines Product Portfolio Table 67. Harrisvaccines, Inc. Recent Development Table 68. Green Cross Veterinary Products Company Information Table 69. Green Cross Veterinary Products Business Overview Table 70. Green Cross Veterinary Products Swine Epidemic Diarrhea Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Green Cross Veterinary Products Swine Epidemic Diarrhea Vaccines Product Portfolio Table 72. Green Cross Veterinary Products Recent Development Table 73. Research Programs/Design for This Report Table 74. Authors List of This Report Table 75. Secondary Sources Table 76. Primary Sources List of Figures Figure 1. Swine Epidemic Diarrhea Vaccines Product Image Figure 2. Global Swine Epidemic Diarrhea Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Swine Epidemic Diarrhea Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Swine Epidemic Diarrhea Vaccines Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Live Vaccines Image Figure 8. Killed Vaccines Image Figure 9. Global Swine Epidemic Diarrhea Vaccines Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Swine Epidemic Diarrhea Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Swine Epidemic Diarrhea Vaccines Sales Value Share by Type (2021-2032) Figure 12. Piglets Image Figure 13. Adults Pigs Image Figure 14. Global Swine Epidemic Diarrhea Vaccines Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Swine Epidemic Diarrhea Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Swine Epidemic Diarrhea Vaccines Sales Value Share by Application (2021-2032) Figure 17. Global Swine Epidemic Diarrhea Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Swine Epidemic Diarrhea Vaccines Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Swine Epidemic Diarrhea Vaccines Sales Value (2021-2032) & (US$ Million) Figure 20. North America Swine Epidemic Diarrhea Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Swine Epidemic Diarrhea Vaccines Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Swine Epidemic Diarrhea Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Swine Epidemic Diarrhea Vaccines Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Swine Epidemic Diarrhea Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Swine Epidemic Diarrhea Vaccines Sales Value (2021-2032) & (US$ Million) Figure 26. South America Swine Epidemic Diarrhea Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Swine Epidemic Diarrhea Vaccines Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Swine Epidemic Diarrhea Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Live Vaccines
  • Killed Vaccines
Applications
  • Piglets
  • Adults Pigs
Companies covered
  • CAVAC
  • Qilu Animal Health
  • Zoetis
  • Nisseiken
  • Komipharm
  • Harrisvaccines, Inc.
  • Green Cross Veterinary Products

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Swine Epidemic Diarrhea Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Swine Epidemic Diarrhea Vaccines Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Swine Epidemic Diarrhea Vaccines Market Dynamics
  1. 2.1 Swine Epidemic Diarrhea Vaccines Industry Trends
  2. 2.2 Swine Epidemic Diarrhea Vaccines Industry Drivers
  3. 2.3 Swine Epidemic Diarrhea Vaccines Industry Opportunities and Challenges
  4. 2.4 Swine Epidemic Diarrhea Vaccines Industry Restraints
3 Swine Epidemic Diarrhea Vaccines Market by Company
  1. 3.1 Global Swine Epidemic Diarrhea Vaccines Company Revenue Ranking in 2025
  2. 3.2 Global Swine Epidemic Diarrhea Vaccines Revenue by Company (2021-2026)
  3. 3.3 Global Swine Epidemic Diarrhea Vaccines Company Ranking (2024-2026)
  4. 3.4 Global Swine Epidemic Diarrhea Vaccines Company Manufacturing Base and Headquarters
  5. 3.5 Global Swine Epidemic Diarrhea Vaccines Company Product Type and Application
  6. 3.6 Global Swine Epidemic Diarrhea Vaccines Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Swine Epidemic Diarrhea Vaccines Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Swine Epidemic Diarrhea Vaccines Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Swine Epidemic Diarrhea Vaccines Market by Type
  1. 4.1 Swine Epidemic Diarrhea Vaccines Type Introduction
  2. 4.1.1 Live Vaccines
  3. 4.1.2 Killed Vaccines
  4. 4.2 Global Swine Epidemic Diarrhea Vaccines Sales Value by Type
  5. 4.2.1 Global Swine Epidemic Diarrhea Vaccines Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Swine Epidemic Diarrhea Vaccines Sales Value by Type (2021-2032)
  7. 4.2.3 Global Swine Epidemic Diarrhea Vaccines Sales Value Share by Type (2021-2032)
5 Swine Epidemic Diarrhea Vaccines Market by Application
  1. 5.1 Swine Epidemic Diarrhea Vaccines Application Introduction
  2. 5.1.1 Piglets
  3. 5.1.2 Adults Pigs
  4. 5.2 Global Swine Epidemic Diarrhea Vaccines Sales Value by Application
  5. 5.2.1 Global Swine Epidemic Diarrhea Vaccines Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Swine Epidemic Diarrhea Vaccines Sales Value by Application (2021-2032)
  7. 5.2.3 Global Swine Epidemic Diarrhea Vaccines Sales Value Share by Application (2021-2032)
6 Swine Epidemic Diarrhea Vaccines Regional Value Analysis
  1. 6.1 Global Swine Epidemic Diarrhea Vaccines Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Swine Epidemic Diarrhea Vaccines Sales Value by Region (2021-2032)
  3. 6.2.1 Global Swine Epidemic Diarrhea Vaccines Sales Value by Region: 2021-2026
  4. 6.2.2 Global Swine Epidemic Diarrhea Vaccines Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Swine Epidemic Diarrhea Vaccines Sales Value (2021-2032)
  7. 6.3.2 North America Swine Epidemic Diarrhea Vaccines Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Swine Epidemic Diarrhea Vaccines Sales Value (2021-2032)
  10. 6.4.2 Europe Swine Epidemic Diarrhea Vaccines Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Swine Epidemic Diarrhea Vaccines Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Swine Epidemic Diarrhea Vaccines Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Swine Epidemic Diarrhea Vaccines Sales Value (2021-2032)
  16. 6.6.2 South America Swine Epidemic Diarrhea Vaccines Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Swine Epidemic Diarrhea Vaccines Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Swine Epidemic Diarrhea Vaccines Sales Value Share by Country, 2025 VS 2032
7 Swine Epidemic Diarrhea Vaccines Country-level Value Analysis
  1. 7.1 Global Swine Epidemic Diarrhea Vaccines Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Swine Epidemic Diarrhea Vaccines Sales Value by Country (2021-2032)
  3. 7.2.1 Global Swine Epidemic Diarrhea Vaccines Sales Value by Country (2021-2026)
  4. 7.2.2 Global Swine Epidemic Diarrhea Vaccines Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Swine Epidemic Diarrhea Vaccines Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Swine Epidemic Diarrhea Vaccines Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Swine Epidemic Diarrhea Vaccines Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 CAVAC
  2. 8.1.1 CAVAC Company Information
  3. 8.1.2 CAVAC Business Overview
  4. 8.1.3 CAVAC Swine Epidemic Diarrhea Vaccines Revenue and Gross Margin (2021-2026)
  5. 8.1.4 CAVAC Swine Epidemic Diarrhea Vaccines Product Portfolio
  6. 8.1.5 CAVAC Recent Developments
  7. 8.2 Qilu Animal Health
  8. 8.2.1 Qilu Animal Health Company Information
  9. 8.2.2 Qilu Animal Health Business Overview
  10. 8.2.3 Qilu Animal Health Swine Epidemic Diarrhea Vaccines Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Qilu Animal Health Swine Epidemic Diarrhea Vaccines Product Portfolio
  12. 8.2.5 Qilu Animal Health Recent Developments
  13. 8.3 Zoetis
  14. 8.3.1 Zoetis Company Information
  15. 8.3.2 Zoetis Business Overview
  16. 8.3.3 Zoetis Swine Epidemic Diarrhea Vaccines Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Zoetis Swine Epidemic Diarrhea Vaccines Product Portfolio
  18. 8.3.5 Zoetis Recent Developments
  19. 8.4 Nisseiken
  20. 8.4.1 Nisseiken Company Information
  21. 8.4.2 Nisseiken Business Overview
  22. 8.4.3 Nisseiken Swine Epidemic Diarrhea Vaccines Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Nisseiken Swine Epidemic Diarrhea Vaccines Product Portfolio
  24. 8.4.5 Nisseiken Recent Developments
  25. 8.5 Komipharm
  26. 8.5.1 Komipharm Company Information
  27. 8.5.2 Komipharm Business Overview
  28. 8.5.3 Komipharm Swine Epidemic Diarrhea Vaccines Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Komipharm Swine Epidemic Diarrhea Vaccines Product Portfolio
  30. 8.5.5 Komipharm Recent Developments
  31. 8.6 Harrisvaccines, Inc.
  32. 8.6.1 Harrisvaccines, Inc. Company Information
  33. 8.6.2 Harrisvaccines, Inc. Business Overview
  34. 8.6.3 Harrisvaccines, Inc. Swine Epidemic Diarrhea Vaccines Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Harrisvaccines, Inc. Swine Epidemic Diarrhea Vaccines Product Portfolio
  36. 8.6.5 Harrisvaccines, Inc. Recent Developments
  37. 8.7 Green Cross Veterinary Products
  38. 8.7.1 Green Cross Veterinary Products Company Information
  39. 8.7.2 Green Cross Veterinary Products Business Overview
  40. 8.7.3 Green Cross Veterinary Products Swine Epidemic Diarrhea Vaccines Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Green Cross Veterinary Products Swine Epidemic Diarrhea Vaccines Product Portfolio
  42. 8.7.5 Green Cross Veterinary Products Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst